查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1988031

藥物輸注系統市場：依產品類型、技術、應用和最終用戶分類－2026-2032年全球市場預測

Drug Infusion Systems Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，藥物輸注系統市場價值將達到 257 億美元，到 2026 年將成長至 275.1 億美元，到 2032 年將達到 410.9 億美元，複合年成長率為 6.93%。

主要市場統計數據
基準年 2025 257億美元
預計年份：2026年 275.1億美元
預測年份 2032 410.9億美元
複合年成長率 (%) 6.93%

從策略觀點探討藥物輸注系統、臨床優先事項、數位整合以及塑造醫療設備發展的變革性照護模式。

藥物輸注系統是現代臨床照護的核心，它能夠在從急診病房到家庭護理等所有醫療環境中實現液體、藥物和營養物質的精準輸注。該領域強調工程技術、臨床工作流程和數位醫療的整合，製造商和醫療服務提供者優先考慮設備的安全性、互通性和患者的移動性。臨床醫生對設備的易用性和警報管理提出了新的要求，而醫療系統提供者則強烈要求設備能夠減少用藥錯誤並與電子健康記錄系統整合。

臨床需求、數位整合和醫療分散化如何從根本上改變產品設計、採購和部署的動態。

在技​​術融合、醫療服務分散化和監管日益嚴格的推動下，輸液系統市場正經歷變革。配備防錯軟體和無線連接功能的智慧輸液泵，正從單純的升級選項轉變為醫療系統中不可或缺的組成部分，旨在減少藥物相關不利事件。因此，軟體品質、網路安全措施以及與電子健康記錄的互通性，對於實現競爭優勢至關重要。

評估截至 2025 年的累積關稅措施對輸液系統的採購決策、成本結構和供應鏈彈性的影響。

到2025年，美國實施的一系列關稅措施的累積影響，正對醫療設備製造商和醫療服務提供者的採購、供應商選擇以及整體產品成本結構造成顯著的下游壓力。許多輸液系統組件及相關耗材都依賴全球分散的供應鏈。無論是提高進口關稅還是引入新的合規要求，關稅都會增加接收成本，並使供應商選擇更加複雜。為此，製造商正在加快供應商分佈圖繪製和雙重採購策略的實施，以減輕關稅對特定產品的影響。

將產品系列、臨床用例、最終用戶需求和技術水準連結起來的詳細細分分析，為策略決策提供支援。

細分市場分析揭示了產品架構、臨床適應症、終端用戶環境和技術層如何相互作用，從而定義價值提案和購買行為。就產品類型而言，攜帶式幫浦、彈性體幫浦、注射式幫浦和容積式幫浦分別滿足不同的臨床需求。攜帶式幫浦又可細分為電池供電型和彈性體型，後者優先考慮患者的移動性。彈性體產品依成本和感染控制的優先性，分為一次性使用型和可重複使用型。注射式幫浦分為攜帶式和固定式，適用於手術和持續輸注等各種情況下的精準給藥。容積式幫浦依輸注速率要求和液體黏度，進一步分為攜帶式型和低流量型。

區域市場動態影響美洲、歐洲、中東和非洲以及亞太地區的監管方式、採購偏好和供應鏈策略。

區域趨勢在輸液系統的監管合規、報銷環境和供應鏈選擇方面發揮核心作用。在美洲，先進的醫院基礎設施、不斷擴展的家庭輸液項目以及支付方對安全性和顯著降低不利事件，正在推動臨床應用。該地區也積極進行關於設備互通性和總體擁有成本 (TCO) 的採購討論，這些討論影響著合約策略和產品商品搭售偏好。

深入了解醫療設備製造商、專業供應商和數位醫療服務提供者匯聚一堂，創造差異化價值提案的競爭格局。

輸液系統領域的競爭格局呈現出多元化的格局，既有大型醫療設備製造商，也有專注於輸液領域的專業公司，還有強調軟體、連接性和分析能力的新興技術供應商。大型製造商通常利用其深厚的臨床夥伴關係關係和廣泛的服務網路為醫院客戶提供支持，提供涵蓋輸液泵、耗材和全生命週期維護的整合解決方案。專業供應商則專注於那些對臨床特異性和安裝空間要求極高的細分市場，例如小型攜帶式輸液泵、彈性體一次性產品和新生兒微量輸液等。

為製造商和醫療保健系統領導者提供可操作且有影響力的策略行動，以推動產品採用、營運韌性和臨床價值的實現。

行業領導者應優先考慮一系列切實可行的舉措，以鞏固市場地位並支持永續成長。首先，他們應迅速將安全連接和互通性標準整合到產品藍圖中，使醫療設備能夠參與藥物管理工作流程和電子健康記錄生態系統。提高軟體品質並建立正式的網路安全流程將有助於減少部署障礙，並滿足醫院的採購要求。

對結合了與關鍵相關人員訪談、監管審查和供應鏈分析的混合研究途徑進行透明的解釋。

本分析的調查方法結合了定性的行業專業知識和結構化的一手及二手研究資訊，以獲得可靠的洞察。主要資訊來源包括對臨床醫生、供應鏈經理和產品經理的訪談，這些訪談涵蓋了營運重點、採購標準和臨床工作流程的限制。這些訪談加深了我們對不同醫療機構中設備功能優先順序、可用性挑戰和支援期望的理解。

簡潔整合策略挑戰，強調互通性、分散式護理設計和供應鏈彈性，以促進採用。

總而言之，我們整合了影響當前輸液系統發展現狀的關鍵主題：轉向更智慧、更互聯的設備的必然趨勢，醫療服務向門診和居家醫療的轉變，以及供應鏈和貿易政策趨勢帶來的營運壓力。利害關係人若能使產品藍圖與互通性預期保持一致，加大對網路安全和軟體品質的投入，並在設計時充分考慮分散式醫療相關人員，將更有能力滿足臨床醫師和病患的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 藥物輸注系統市場：依產品類型分類

  • 攜帶式泵浦
    • 電池供電
    • 由彈性體製成
  • 彈性體泵
    • 一次性的
    • 可重複使用的
  • 注射式幫浦
    • 攜帶式的
    • 固定式
  • 容積式泵
    • 高流速
    • 低流量

第9章：藥物輸注系統市場：依技術分類

  • 非智慧泵
  • 智慧泵浦
    • 有線
    • 無線的

第10章 藥物輸注系統市場：依應用領域分類

  • 重症監護
  • 胃腸病學
  • 新生兒醫學
  • 腫瘤學
  • 疼痛管理

第11章 藥物輸注系統市場：依最終使用者分類

  • 門診部
  • 居家醫療
  • 醫院
  • 專科診所

第12章 藥物輸注系統市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 藥物輸注系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 藥物輸注系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國輸液系統市場

第16章：中國輸液系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AKAS Infusions
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson, and Company
  • Debiotech SA
  • Eitan Medical
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Halyard Health, Inc.
  • ICU Medical Inc.
  • Insulet Corporation
  • Intera Oncology Inc.
  • IRADIMED CORPORATION
  • Ivenix Inc.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Microport Scientific Corporation
  • MOOG, Inc.
  • Promecon GmbH
  • SINO MDT
  • Smiths Group plc
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-F97DD5A7D582

The Drug Infusion Systems Market was valued at USD 25.70 billion in 2025 and is projected to grow to USD 27.51 billion in 2026, with a CAGR of 6.93%, reaching USD 41.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 25.70 billion
Estimated Year [2026] USD 27.51 billion
Forecast Year [2032] USD 41.09 billion
CAGR (%) 6.93%

A strategic orientation to drug infusion systems that frames clinical priorities, digital convergence, and care model shifts shaping device development

Drug infusion systems are central to modern clinical care, enabling precise delivery of fluids, therapeutics, and nutrition across settings from acute hospital wards to home-based therapies. The introduction to this landscape emphasizes the convergence of engineering, clinical workflows, and digital health, as manufacturers and providers prioritize device safety, interoperability, and patient mobility. Emerging expectations from clinicians emphasize usability and alarm management, while health systems are pressing for devices that reduce medication errors and integrate with electronic health records.

Technological advances have broadened the scope of infusion devices beyond traditional pump mechanics to include embedded software, wireless connectivity, and data-driven dosing safeguards. Simultaneously, care delivery models are shifting toward decentralized and ambulatory settings, elevating demand for compact, battery-operated ambulatory pumps and single-use disposables that support outpatient infusion. Supply chain dynamics and regulatory scrutiny further shape product design decisions, compelling vendors to balance reliability, sterilization workflows, and cost control.

This introduction situates the reader to understand how clinical imperatives, regulatory frameworks, and technology trends combine to influence product development and adoption, setting the stage for deeper analysis of market drivers, segmentation nuances, and strategic priorities for stakeholders across the value chain.

How clinical imperatives, digital integration, and care decentralization are fundamentally reshaping product design, procurement, and adoption dynamics

The drug infusion systems landscape is undergoing transformative shifts driven by technology integration, care decentralization, and heightened regulatory focus. Smart pumps equipped with dose-error-reduction software and wireless connectivity are moving from optional upgrades to expected components in health systems seeking to reduce adverse drug events. As a result, software quality, cybersecurity safeguards, and interoperability with electronic medical records have become central competitive differentiators.

At the same time, the growth of outpatient and home infusion care has accelerated demand for ambulatory and elastomeric solutions engineered for portability, simplified user interfaces, and extended battery performance. This transition from facility-centric to patient-centric delivery necessitates a reimagining of training, disposables management, and remote monitoring capabilities. Contract manufacturing and modular product architectures are also reshaping product roadmaps, enabling faster iterations and regional customization.

Operationally, clinical teams and procurement functions are prioritizing devices that reduce complexity, minimize alarm fatigue, and integrate into medication management workflows. These combined forces are redefining product value propositions, with vendors that can demonstrate clinical outcomes, secure connectivity, and lifecycle support poised to capture sustained preference among health systems and home-care providers.

Assessment of how cumulative tariff measures through 2025 have reshaped sourcing decisions, cost structures, and supply chain resilience for infusion systems

The cumulative effects of tariff actions implemented in the United States through 2025 have created notable downstream pressures across procurement, sourcing, and product cost structures for medical device manufacturers and healthcare providers. Many infusion system components and ancillary consumables rely on globally distributed supply chains; tariffs that raise import duties or introduce new compliance requirements increase landed costs and complicate supplier selection. In response, manufacturers have accelerated supplier mapping and dual-sourcing strategies to mitigate exposure to specific tariff lines.

These shifts are prompting manufacturers to reassess the geographic composition of their bills of materials and to explore regional nearshoring options for critical subassemblies. That transition carries its own trade-offs, including requalification timelines, higher labor inputs in some jurisdictions, and capital investments in local manufacturing capabilities. For downstream purchasers, higher component costs can translate into pressure on margins or incrementally higher device and consumable pricing unless offset by process efficiencies or longer-term contracts.

Clinicians and hospital procurement teams have reacted by emphasizing total cost of ownership analyses, looking beyond the sticker price to consider service agreements, consumable usage profiles, and device longevity. Meanwhile, the cumulative tariff environment has elevated the importance of supply chain transparency, contractual flexibility, and scenario planning to preserve continuity of care while managing cost trajectories under evolving trade policies.

Detailed segmentation intelligence connecting product families, clinical use-cases, end-user requirements, and technology tiers to inform strategic choices

Segmentation analysis reveals how product architectures, clinical indications, end-user environments, and technology layers interact to define value propositions and purchasing behavior. When considering product type, Ambulatory Pumps, Elastomeric Pumps, Syringe Pumps, and Volumetric Pumps each address distinct clinical needs: the Ambulatory Pumps subgroup includes battery-operated devices and elastomeric variants that emphasize patient mobility; elastomeric offerings break down into disposable and reusable models that balance cost and infection-control priorities; syringe pumps appear as portable and stationary variants serving precision dosing in both procedural and continuous-infusion contexts; and volumetric pumps divide into high-flow and low-flow categories tailored to infusion rate requirements and fluid viscosity considerations.

Application-based segmentation shows how clinical areas such as Critical Care, Gastroenterology, Neonatal Care, Oncology, and Pain Management exert differentiated requirements on pump features, alarm profiles, and consumable compatibility. Critical care demands rigorous redundancy and integration with monitoring systems, neonatal care prioritizes microflow accuracy and low-dead-space consumables, oncology requires robust ambulatory solutions for outpatient chemotherapy administration, while pain management and gastroenterology focus on patient comfort and ease of use in both clinic and home settings.

End-user segmentation across Ambulatory Care Centers, Home Healthcare, Hospitals, and Specialty Clinics drives procurement criteria and support models, with hospitals emphasizing service contracts and interoperability, home healthcare prioritizing portability and caregiver simplicity, ambulatory centers seeking throughput and turnover efficiencies, and specialty clinics requiring targeted features for niche therapies. Technology segmentation between Non-Smart Pumps and Smart Pumps, where smart variants further bifurcate into wired and wireless implementations, illustrates a spectrum of connectivity and software dependency that influences lifecycle support, cybersecurity planning, and integration costs. Understanding how these segmentation axes intersect enables product teams and purchasers to align specifications with clinical workflows and long-term operational needs.

Regional market dynamics that shape regulatory approaches, procurement preferences, and supply chain strategies across Americas, EMEA, and Asia-Pacific

Regional dynamics play a central role in shaping regulatory compliance, reimbursement environments, and supply chain options for infusion systems. In the Americas, clinical adoption is driven by advanced hospital infrastructures, expanding home-infusion programs, and payer scrutiny that emphasizes safety and demonstrable reductions in adverse medication events. This region also exhibits active procurement dialogues about device interoperability and total cost of ownership, which influences contracting strategies and product bundling preferences.

Europe, the Middle East & Africa present a diverse set of regulatory frameworks and heterogeneous purchasing power, creating opportunities for flexible product configurations and regional partnerships. In parts of this region, centralized procurement and national health systems exert significant influence on device standards and supplier selection, while other markets favor private-sector innovation adoption. Compliance with region-specific medical device directives and post-market surveillance requirements adds a layer of complexity for manufacturers operating across these jurisdictions.

Asia-Pacific shows rapid adoption of ambulatory and home-care models in urban centers, coupled with expanding domestic manufacturing capabilities that can support export-oriented supply chains. Regulatory modernization and emphasis on local clinical validation are accelerating, and strategic alliances between global OEMs and regional partners are common. These regional contrasts require tailored go-to-market approaches, regulatory intelligence, and supply chain configurations to match both clinical needs and procurement realities.

Insights into the competitive ecosystem where device manufacturers, specialized vendors, and digital-health providers converge to create differentiated value propositions

Competitive landscapes in the infusion systems sector are characterized by a mix of large diversified medical device manufacturers, specialized infusion-focused firms, and emergent technology providers that emphasize software, connectivity, and analytics. Leading manufacturers typically leverage deep clinical partnerships and broad service networks to support hospital customers, offering integrated solutions that span pumps, consumables, and lifecycle maintenance. Specialized vendors focus on niche requirements-such as compact ambulatory pumps, elastomeric disposables, or neonatal microinfusion-to capture segments where clinical specificity and minimal footprint matter.

At the same time, software and connectivity players are changing the equation by supplying dose management, interoperability middleware, and cloud-based analytics that extract value from device telemetry. Contract manufacturers and component suppliers continue to exert influence through design for manufacturability and the availability of validated subassemblies. Across these archetypes, competitive differentiation increasingly hinges on the ability to demonstrate clinical outcomes, secure connectivity, and robust post-market support, while managing production costs and supply chain transparency.

For stakeholders evaluating partnerships or M&A, attention should be paid to how potential partners address regulatory compliance pathways, cybersecurity risk management, and service delivery models required by diverse end users. Collaboration between device makers and digital-health firms is a particularly fertile area for value creation, enabling evidence-based care pathways and remote monitoring that enhance both clinical and commercial propositions.

Practical, high-impact strategic actions for manufacturers and health-system leaders to advance product adoption, operational resilience, and clinical value delivery

Industry leaders should prioritize a set of actionable initiatives to secure market position and support sustainable growth. First, accelerate integration of secure connectivity and interoperability standards into product roadmaps so that devices can participate in medication management workflows and electronic medical record ecosystems. Enhancing software quality and establishing formal cybersecurity processes will reduce adoption friction and support hospital procurement requirements.

Second, invest in product designs and service models tailored to decentralized care, including robust ambulatory pumps, simplified user interfaces, and consumable strategies that minimize caregiver burden. Parallel to product innovation, strengthen supply chain resilience by diversifying suppliers, qualifying regional partners, and developing contingency plans that mitigate exposure to trade policy changes. These steps will preserve continuity of supply and support responsive pricing strategies.

Third, build evidence that ties device use to clinical outcomes and operational efficiencies through pragmatic clinical studies and real-world data collection. Such evidence improves procurement positioning and supports value-based contracting. Finally, pursue strategic collaborations with software vendors and clinical organizations to develop integrated solutions that combine hardware reliability with data-driven dosing safeguards and remote monitoring capabilities. Together, these actions will help organizations adapt to evolving clinical expectations and procurement frameworks.

Transparent description of the mixed-methods research approach that blends primary stakeholder interviews, regulatory review, and supply chain analysis

The research methodology underpinning this analysis combined qualitative industry expertise with structured primary and secondary intelligence gathering to ensure robust insights. Primary inputs included interviews with clinicians, supply chain managers, and product leaders, capturing operational priorities, procurement criteria, and clinical workflow constraints. These conversations informed the interpretation of device feature priorities, usability challenges, and support expectations across care settings.

Secondary research involved systematic review of regulatory guidance, standards applicable to infusion pumps, published clinical literature on safety and usability, and public filings related to device recalls and safety communications. Supply chain and trade policy analysis drew on customs classification trends and public tariff announcements to assess potential impacts on component sourcing and procurement practices. Where relevant, case examples and anonymized field observations were used to illustrate adoption patterns and integration challenges.

Throughout the methodology, triangulation was applied to reconcile insights from multiple sources, with attention to regional differentiation and clinical specialty needs. Findings were synthesized to highlight strategic implications for product design, market entry, and operational practices rather than to produce granular market-sizing outputs.

A concise synthesis of strategic imperatives emphasizing interoperability, decentralized care design, and supply chain resilience to drive adoption

The conclusion synthesizes the principal themes affecting the drug infusion systems landscape: the inexorable shift toward smarter, connected devices; the migration of care into ambulatory and home settings; and the operational pressures induced by supply chain and trade policy dynamics. Stakeholders who align product roadmaps with interoperability expectations, invest in cybersecurity and software quality, and design for decentralized care environments will be better positioned to meet clinician and patient needs.

At the same time, supply chain resilience and regional manufacturing considerations have become strategic imperatives in light of tariff and trade uncertainties. Providers and manufacturers that adopt flexible sourcing, evidence-driven value propositions, and collaborative commercial models are more likely to sustain adoption momentum. The interplay of clinical safety, regulatory compliance, and technology enablement will continue to define competitive differentiation in the sector.

Ultimately, success will depend on the ability to integrate engineering excellence with operational realities and clinical evidence, delivering infusion solutions that are safe, intuitive, and support evolving care pathways across acute and non-acute settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Drug Infusion Systems Market, by Product Type

  • 8.1. Ambulatory Pumps
    • 8.1.1. Battery Operated
    • 8.1.2. Elastomeric
  • 8.2. Elastomeric Pumps
    • 8.2.1. Disposable
    • 8.2.2. Reusable
  • 8.3. Syringe Pumps
    • 8.3.1. Portable
    • 8.3.2. Stationary
  • 8.4. Volumetric Pumps
    • 8.4.1. High Flow
    • 8.4.2. Low Flow

9. Drug Infusion Systems Market, by Technology

  • 9.1. Non-Smart Pumps
  • 9.2. Smart Pumps
    • 9.2.1. Wired
    • 9.2.2. Wireless

10. Drug Infusion Systems Market, by Application

  • 10.1. Critical Care
  • 10.2. Gastroenterology
  • 10.3. Neonatal Care
  • 10.4. Oncology
  • 10.5. Pain Management

11. Drug Infusion Systems Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Healthcare
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Drug Infusion Systems Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Drug Infusion Systems Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Drug Infusion Systems Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Drug Infusion Systems Market

16. China Drug Infusion Systems Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AKAS Infusions
  • 17.6. B. Braun SE
  • 17.7. Baxter International, Inc.
  • 17.8. Becton, Dickinson, and Company
  • 17.9. Debiotech S.A.
  • 17.10. Eitan Medical
  • 17.11. Flowonix Medical Inc.
  • 17.12. Fresenius Kabi AG
  • 17.13. Fresenius SE & Co. KGaA
  • 17.14. Halyard Health, Inc.
  • 17.15. ICU Medical Inc.
  • 17.16. Insulet Corporation
  • 17.17. Intera Oncology Inc.
  • 17.18. IRADIMED CORPORATION
  • 17.19. Ivenix Inc.
  • 17.20. Medtronic Plc
  • 17.21. Micrel Medical Devices SA
  • 17.22. Microport Scientific Corporation
  • 17.23. MOOG, Inc.
  • 17.24. Promecon GmbH
  • 17.25. SINO MDT
  • 17.26. Smiths Group plc
  • 17.27. Tandem Diabetes Care, Inc.
  • 17.28. Teleflex Incorporated
  • 17.29. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HIGH FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HIGH FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HIGH FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY LOW FLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY LOW FLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY LOW FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY NON-SMART PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY NON-SMART PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY NON-SMART PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY NEONATAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY NEONATAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY NEONATAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. GCC DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 212. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 222. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 223. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY AMBULATORY PUMPS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY ELASTOMERIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY SYRINGE PUMPS, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY VOLUMETRIC PUMPS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY SMART PUMPS, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)